Colibri Heart Valve Strengthens Patent Portfolio with Receipt of 12th Transcatheter Heart Valve (THV) Patent
24. August 2015 08:00 ET
|
Colibri Heart Valve LLC
BROOMFIELD, CO, Aug. 24, 2015 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, has received an Issue Notification from the U.S. Patent and Trademark...
Colibri Heart Valve Receives Patent for Controlled Release of a Percutaneous Heart Valve Device and Strengthens Management Team
16. April 2015 08:00 ET
|
Colibri Heart Valve LLC
Broomfield, CO, April 16, 2015 (GLOBE NEWSWIRE) -- Colibri Heart Valve,
LLC, a privately held emerging medical device company, has
received its 8th allowed/granted patent directed to
transcatheter...
Colibri Heart Valve's TAVI system Continues to Show Positive Long-Term Results from its First-in-Human Clinical Study
12. September 2014 09:00 ET
|
Colibri Heart Valve LLC
BROOMFIELD, CO, Sept. 12, 2014 (GLOBE NEWSWIRE) -- Colibri Heart Valve,
LLC, a privately held emerging medical device company, today
announced that long-term results on patients enrolled in...
Colibri Heart Valve to Present Long-Term Results from the Company's First-in-Human Clinical Study and Exhibit at Upcoming EuroPCR Meeting
13. Mai 2014 08:00 ET
|
Colibri Heart Valve LLC
BROOMFIELD, CO, May 13, 2014 (GLOBE NEWSWIRE) -- Colibri Heart Valve,
LLC, a privately held emerging medical device company, today
announced that Dr. Bernard Chevalier will present long-term
findings...
Colibri Heart Valve Announces Clinical Update in the Company's Feasibility Study of the First Ready-to-Use Transcatheter Heart Valve System
03. Februar 2014 13:00 ET
|
Colibri Heart Valve LLC
BROOMFIELD, CO, Feb. 3, 2014 (GLOBE NEWSWIRE) -- Colibri Heart Valve,
LLC, a privately held emerging medical device company, has
shared findings from long-term follow-up of patients enrolled in
the...
Colibri Heart Valve Concludes Patient Enrollment in First-in-Human Study of Proprietary TAVI System in Dominican Republic
24. Oktober 2013 08:00 ET
|
Colibri Heart Valve LLC
BROOMFIELD, CO, Oct. 24, 2013 (GLOBE NEWSWIRE) -- Colibri Heart Valve,
LLC, a privately held medical device company, announced that
patient enrollment has concluded in the first-in-human study of...
Colibri Heart Valve Announces Continued Enrollment in the Company's Feasibility Study of the First Ready-to-Use Transcatheter Heart Valve System
24. Juli 2013 08:00 ET
|
Colibri Heart Valve LLC
BROOMFIELD, CO, July 24, 2013 (GLOBE NEWSWIRE) -- Colibri Heart Valve,
LLC, a privately held medical device company, today announced
that enrollment in the Company's first-in-human feasibility...
Colibri Heart Valve to Present Six Month Follow-up Results from First Clinical Use at Upcoming EuroPCR Meeting
16. Mai 2013 08:00 ET
|
Colibri Heart Valve LLC
BROOMFIELD, CO, May 16, 2013 (GLOBE NEWSWIRE) -- Colibri Heart Valve,
LLC, a privately held medical device company, today announced
that Dr. Pedro Ureña will present six month follow-up results...
Colibri Heart Valve Announces Issuance of a Patent for a Pre-mounted, Pre-packaged, Sterilized Dry Heart Valve on a Delivery System
29. Januar 2013 08:00 ET
|
Colibri Heart Valve LLC
BROOMFIELD, CO, Jan. 29, 2013 (GLOBE NEWSWIRE) -- Colibri Heart Valve,
LLC, a privately held medical device company, has been granted
yet another patent directed to prosthetic heart valves. ...
Colibri Heart Valve, LLC Announces Successful Clinical Use of the First Ready-to-Use Transcatheter Aortic Heart Valve System
05. Dezember 2012 08:00 ET
|
Colibri Heart Valve LLC
BROOMFIELD, CO, Dec. 5, 2012 (GLOBE NEWSWIRE) -- Colibri Heart Valve, LLC
today announced that it has successfully completed the first
clinical use of the Company's proprietary transcatheter...